John E. Macor

6.1k citations

161 papers · 3.2k indexed · h-index 29

Organic Chemistry top 1%
- Synthesis and Biological Evaluation 25
- Asymmetric Synthesis and Catalysis 20
- Chemical Reaction Mechanisms 17
- Chemical synthesis and alkaloids 16
Cellular and Molecular Neuroscience top 2%
- Neuroscience and Neuropharmacology Research 22
- Neuropeptides and Animal Physiology 21
Pharmacology top 2%
Pharmaceutical Science top 2%
Psychiatry and Mental health top 5%
- Migraine and Headache Studies 18
Molecular Biology
- Receptor Mechanisms and Signaling 30

Co-authors: Edward C. Taylor Kevin Ryan Michael E. Newman B. Kenneth Koe Gene M. Dubowchik James Heym Ronald J. Post Lorraine A. Lebel
Cited by: Organic Chemistry Cellular and Molecular Neuroscience Pharmacology
Journals: Bioorganic & Medicinal Chemistry Letters (53 papers)Tetrahedron Letters (24 papers)Journal of Medicinal Chemistry (18 papers)
Partner nations: United States Germany India

In The Last Decade

John E. Macor

159 papers receiving 3.1k citations

Peers

Countries citing papers authored by John E. Macor

Since Specialization

Citations

This map shows the geographic impact of John E. Macor's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John E. Macor with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John E. Macor more than expected).

Fields of papers citing papers by John E. Macor

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by John E. Macor. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John E. Macor. The network helps show where John E. Macor may publish in the future.

Co-authorship network

The 25 scholars most cited alongside John E. Macor, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with John E. Macor Line = papers co-authored together John E. Macor links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Site-Selective C–H Functionalization of N-Aryl and N-Heteroaryl Piperidines, Morpholines, and Piperazines Controlled by a Chiral Dirhodium Tetracarboxylate Catalyst ACS Catalysis ·Korkit Korvorapun,Zhengwang Zhu,Thomas Maier,Armin Bauer,Thomas Licher,John E. Macor,Volker Derdau,Huw M. L. Davies	2023	9
2	Identification of RIPK3 Type II Inhibitors Using High-Throughput Mechanistic Studies in Hit Triage ACS Medicinal Chemistry Letters ·Amy C. Hart,Lynn M. Abell,Junqing Guo,Michael Mertzman,Ramesh Padmanabha,John E. Macor,Charu Chaudhry,Hao Lu,K O'Malley,Patrick J. Shaw,Carolyn A. Weigelt,Matthew Pokross,Kevin Kish,Kyoung S. Kim,Lyndon A. M. Cornelius,Lisle W Blackbourn,Huang XiYang,Ping Zhang,Brian Carpenter,William J. Pitts	2019	31
3	[ 3 H]BMT-046091 a potent and selective radioligand to determine AAK1 distribution and target engagement Neuropharmacology ·Justin Vijay Louis,Yifeng Lu,Rick L. Pieschl,Ahmed N. M. El-atla,И.В. Батунова,Олена Петрівна Вавріневич,Astrid Marie Møller Danielsen,Reeba K. Vikramadithyan,Carolyn D. Dzierba,Sunny Malik,Susheel J. Nara,Joanne J. Bronson,John E. Macor,Jose Carugno,Walter A. Kostich,Yu-Wen Li	2017	6
4	B-973, a novel piperazine positive allosteric modulator of the α7 nicotinic acetylcholine receptor European Journal of Pharmacology ·Debra J. Post-Munson,Rick L. Pieschl,Thaddeus F. Molski,John D. Graef,Adam Hendricson,Ronald J. Knox,Ivar M. McDonald,Richard E. Olson,John E. Macor,Michael R. Weed,Linda J. Bristow,Laszlo Kiss,Michael K. Ahlijanian,James Herrington	2017	16
5	Synthesis and evaluation of prodrugs of corticotropin-releasing factor-1 (CRF1) receptor antagonist BMS-665053 leading to improved oral bioavailability Bioorganic & Medicinal Chemistry Letters ·Richard A. Hartz,Vivekananda M. Vrudhula,Vijay T. Ahuja,James E. Grace,Nicholas J. Lodge,Joanne J. Bronson,John E. Macor	2017	3
6	Synthesis and SAR of calcitonin gene-related peptide (CGRP) antagonists containing substituted aryl-piperazines and piperidines Bioorganic & Medicinal Chemistry Letters ·Rita L. Civiello,Xiaojun Han,Brett R. Beno,Bruno Ferlin,John J. Herbst,Cen Xu,Charles M. Conway,John E. Macor,Gene M. Dubowchik	2016	4
7	Oxazolidinone-based allosteric modulators of mGluR5: Defining molecular switches to create a pharmacological tool box Bioorganic & Medicinal Chemistry Letters ·Hong Huang,Andrew P. Degnan,Anand Balakrishnan,Amy Easton,Michael Gulianello,Yanling Huang,Kathryn H. Chace,Gail K. Mattson,Tian Gao,Kenneth S. Santone,Arun Senapati,Whin Themas Mico Saputra,Digavalli V. Sivarao,Lawrence B. Snyder,Ryan S. Westphal,Valerie Whiterock,Fukang Yang,Joanne J. Bronson,John E. Macor	2016	21
8	Biochemical and behavioral effects of PDE10A inhibitors: Relationship to target site occupancy Neuropharmacology ·Yu-Wen Li,Matthew A. Seager,Fauzi Setianto,Karen Heman,Thaddeus F. Molski,Alda Fernandes,Liao Su-qu,Annapurna Pendri,Samuel W. Gerritz,Yuan Tian,Hong Yang,Nathaniel Knox-Cartwright,J. Robert Merritt,O. M. Kind,Ryan S. Westphal,Robert Zaczek,John E. Macor,Joanne J. Bronson,Nicholas J. Lodge	2015	15
9	Design and optimization of tricyclic gamma-secretase modulators Bioorganic & Medicinal Chemistry Letters ·D Mangin Patrice,Dmitry Zuev,Li Xu,Kimberley A. Lentz,James E. Grace,Jeremy H. Toyn,Richard E. Olson,John E. Macor,Lorin A. Thompson	2015	11
10	Discovery of a novel series of quinolone α7 nicotinic acetylcholine receptor agonists Bioorganic & Medicinal Chemistry Letters ·Ivar M. McDonald,Robert Mate,F. Christopher Zusi,Hong Huang,Debra J. Post-Munson,Daiki Kayano,Nathaniel Knox-Cartwright,Robert L. Bertekap,Ronald J. Knox,Barbara Robertson,David Harden,Daniel G. Morgan,Nicholas J. Lodge,Steven I. Dworetzky,Richard E. Olson,John E. Macor	2013	16
11	2-(N-Benzyl-N-phenylsulfonamido)alkyl amide derivatives as γ-secretase inhibitors Bioorganic & Medicinal Chemistry Letters ·Michael F. Parker,Donna M. Barten,Carl P. Bergstrom,Joanne J. Bronson,Jason A. Corsa,Michael F. Dee,Remco G.W. Nijman,Valerie Guss,Elisabeth Vogelheim,R. P. H. 'Neill,Alice Loo,Robert Mate,Asma Hilyah Al-Aulia,Carl Hartman,Craig Polson,Susan B. Roberts,John E. Macor	2012	2
12	Potential CRF1R PET imaging agents: N-Fluoroalkyl-8-(6-methoxy-2-methylpyridin-3-yl)-2,7-dimethyl-N-alkylpyrazolo[1,5-a][1,3,5]triazin-4-amines Bioorganic & Medicinal Chemistry Letters ·Dmitry Zuev,Ronald J. Mattson,Hong Huang,Gail K. Mattson,Nina Kazachek,Deshayes,Jože Manfreda,Xiaohua Huang,Dedong Wu,Qi Gao,Nicholas J. Lodge,Joanne J. Bronson,John E. Macor	2011	16
13	Synthesis and SAR of hydroxyethylamine based phenylcarboxyamides as inhibitors of BACE Bioorganic & Medicinal Chemistry Letters ·Yong‐Jin Wu,Yunhui Zhang,Andrew C. Good,Catherine R. Burton,Jeremy H. Toyn,Charles F. Albright,John E. Macor,Lorin A. Thompson	2009	11
14	Conformationally restricted homotryptamines. Part 5: 3-(trans-2-aminomethylcyclopentyl)indoles as potent selective serotonin reuptake inhibitors Bioorganic & Medicinal Chemistry Letters ·Derek J. Denhart,Jeffrey A. Deskus,Jonathan L. Ditta,Qi Gao,Dalton King,Jože Manfreda,Zhaoxing Meng,Haili Zhang,Gail K. Mattson,Thaddeus F. Molski,Matthew T. Taber,Nicholas J. Lodge,Ronald J. Mattson,John E. Macor	2009	24
15	β-Alanine dipeptides as MC4R agonists Bioorganic & Medicinal Chemistry Letters ·Réjean Ruel,Timothy F. Herpin,Lawrence G. Iben,Guanglin Luo,Alain Martel,Helen S. Mason,Gail K. Mattson,Brigitte Poirier,Edward H. Ruediger,Dan Shi,William E. Boyd,Guixue Yu,I Zimányi,Graham S. Poindexter,John E. Macor	2003	17
16	Discovery of 4′-[(Imidazol-1-yl)methyl]biphenyl-2-sulfonamides as dual endothelin/Angiotensin II receptor antagonists Bioorganic & Medicinal Chemistry Letters ·John E. Tellew,Gavin Ryan,Sophie Beyer,Kenneth E. Carlson,Lyndon A. M. Cornelius,Ruru Wang,Zhengxiang Gu,Nina Perlita,Mark C. Kowala,Hossain Monshizadegan,Natesan Murugesan,Carol S. Ryan,Maria Valentine,Yifan Yang,John E. Macor	2003	13
17	The discovery of novel, potent and selective PDE5 inhibitors Bioorganic & Medicinal Chemistry Letters ·Yingzhi Bi,Patrick Stoy,Leonard P. Adam,Bin He,John Krupinski,Diane E. Normandin,Florence C. Myers,Laurie Seliger,Andrew J. Watson,John E. Macor	2001	21
18	Characterization of [³H]CP‐96,501 as a Selective Radioligand for the Serotonin 5‐HT_1B Receptor: Binding Studies in Rat Brain Membranes Journal of Neurochemistry ·B. Kenneth Koe,Lorraine A. Lebel,Carol B. Fox,John E. Macor	1992	20
19	Synthesis and serotonergic pharmacology of the enantiomers of 3-[(N-methylpyrrolidin-2-yl)methyl]-5-methoxy-1H-indole: discovery of stereogenic differentiation in the aminoethyl side chain of the neurotransmitter serotonin Journal of Medicinal Chemistry ·John E. Macor,C. Clamageran,Carol B. Fox,Janko Pejovic,B. Kenneth Koe,Lorraine A. Lebel,Jean Morrone,Kevin Ryan,Anne W. Schmidt	1992	14
20	3-(1,2,5,6-Tetrahydropyrid-4-yl)pyrrolo[3,2-b]pyrid-5-one: a potent and selective serotonin (5-HT1) agonist and rotationally restricted phenolic analog of 5-methoxy-3-(1,2,5,6-tetrahydropyrid-4-yl)indole Journal of Medicinal Chemistry* ·John E. Macor,Catherine A. Burkhart,James Heym,Jeffrey L. Ives,Lorraine A. Lebel,Michael E. Newman,J.A. Nielsen,Kevin Ryan,David W. Schulz	1990	138

About John E. Macor

John E. Macor is a scholar working on Cellular and Molecular Neuroscience, Organic Chemistry and Behavioral Neuroscience, having authored 161 papers that have together received 3.2k indexed citations. Recurring topics across this work include Receptor Mechanisms and Signaling (30 papers), Synthesis and Biological Evaluation (25 papers), Neuroscience and Neuropharmacology Research (22 papers), Neuropeptides and Animal Physiology (21 papers), Asymmetric Synthesis and Catalysis (20 papers), Migraine and Headache Studies (18 papers), Chemical Reaction Mechanisms (17 papers) and Chemical synthesis and alkaloids (16 papers). The work is most often cited by research in Organic Chemistry (1.5k citations), Cellular and Molecular Neuroscience (691 citations) and Pharmacology (395 citations). John E. Macor has collaborated with scholars based in United States, Germany and India. Frequent co-authors include Edward C. Taylor, Kevin Ryan, Michael E. Newman, B. Kenneth Koe, Gene M. Dubowchik, Edward C. Taylor, James Heym, Ronald J. Post, Lorraine A. Lebel and Robert A. Mack. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Tetrahedron Letters, Journal of Medicinal Chemistry, The Journal of Organic Chemistry and ACS Medicinal Chemistry Letters.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact